SCHEMBL5180841

SCHEMBL5180841

COc1cc(CC/C=N/NC(=N)N)n(-c2ccccc2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 1/20 0.34
▸ MTNR1B P49286 1/20 0.34
▸ MAPT P10636 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ MEN1 O00255 4/20 0.32
▸ KMT2A Q03164 4/20 0.32
▸ HTR6 P50406 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ RXFP3 Q9NSD7 1/20 0.32
▸ ALPL P05186 1/20 0.31
▸ ALPI P09923 1/20 0.31
▸ ALPG P10696 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4185993 0.80 SMN1; SMN2 (0.35) MTNR1AMTNR1BMAPTALDH1A1KDM4E
SCHEMBL4185988 0.80 SMN1; SMN2 (0.35) MTNR1AMTNR1BMAPTALDH1A1KDM4E
SCHEMBL4179681 0.78 KDM4E (0.39) MAPTALDH1A1KDM4ELMNARAB9A
SCHEMBL4179685 0.78 KDM4E (0.39) MAPTALDH1A1KDM4ELMNARAB9A
SCHEMBL12123685 0.77 MAPT (0.39) MTNR1AMTNR1BMAPTALDH1A1KDM4E
SCHEMBL4179754 0.75 HTR6 (0.39) MTNR1AMTNR1BALDH1A1KDM4ENPC1
SCHEMBL5180273 0.73 ALDH1A1 (0.44) MAPTALDH1A1KDM4ESMN1; SMN2MEN1
SCHEMBL5180267 0.73 ALDH1A1 (0.44) MAPTALDH1A1KDM4ESMN1; SMN2MEN1
SCHEMBL4193434 0.71 — —
SCHEMBL4193429 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1414440-B1 N-PHENYLPYRROLE GUANIDINE DERIVATIVES AS MELANOCORTIN RECEPTOR LIGANDS ACTION PHARMA AS (DK) 2007-01-10 — — EP claimed
US-20060148798-A1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands ACTION PHARMA A/S (DK) 2006-07-06 — — US claimed
EP-1414440-B1 N-PHENYLPYRROLE GUANIDINE DERIVATIVES AS MELANOCORTIN RECEPTOR LIGANDS ACTION PHARMA AS (DK) 2007-01-10 — — EP disclosed
US-20060148798-A1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands ACTION PHARMA A/S (DK) 2006-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148798-A1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands MC1R, MC5R, MC3R MTNR1A 42/4885MTNR1B 50/4885MAPT 3844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback